ADENTRA (TSE:ADEN) Price Target Raised to C$51.00 at Stifel Nicolaus

ADENTRA (TSE:ADENGet Free Report) had its price objective lifted by equities research analysts at Stifel Nicolaus from C$49.50 to C$51.00 in a research note issued on Friday,BayStreet.CA reports. The brokerage currently has a “buy” rating on the stock.

Several other brokerages have also recently weighed in on ADEN. ATB Cormark Capital Markets raised their price target on shares of ADENTRA from C$50.00 to C$61.00 and gave the stock an “outperform” rating in a research note on Friday, March 13th. National Bank Financial decreased their price target on shares of ADENTRA from C$54.50 to C$52.00 and set an “outperform” rating for the company in a research note on Friday, March 13th. Finally, Scotiabank raised their price target on shares of ADENTRA from C$41.00 to C$46.00 in a research note on Thursday, January 29th. Five equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat, ADENTRA has an average rating of “Moderate Buy”.

Check Out Our Latest Stock Analysis on ADEN

ADENTRA Price Performance

Shares of ADEN traded up $2.51 during mid-day trading on Friday, hitting $36.62. 38,181 shares of the company’s stock were exchanged, compared to its average volume of 50,193. The company has a market cap of $887.85 million, a PE ratio of 13.51 and a beta of 1.39. ADENTRA has a 52 week low of $24.60 and a 52 week high of $41.20. The company has a 50-day simple moving average of $35.97 and a 200 day simple moving average of $35.09.

ADENTRA Company Profile

(Get Free Report)

Adentra Inc is a distributor of architectural products to fabricators, home centers and professional dealers servicing the new residential, repair and remodel, and commercial construction end markets. The company operates a network in North America of 86 facilities in the United States and Canada.

See Also

Analyst Recommendations for ADENTRA (TSE:ADEN)

Receive News & Ratings for ADENTRA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ADENTRA and related companies with MarketBeat.com's FREE daily email newsletter.